Time-dependent cost comparison and health economic impact analysis of second-line interventions for transplant-ineligible patients with relapsed or refractory diffuse large B cell lymphoma.
Melina Sophie KurteAnn-Cathrine SiefenFlorian JakobsTabea PoosJulia von TresckowBastian von TresckowHans Christian ReinhardtFlorian KronPublished in: European journal of haematology (2024)
Analyses uncovered a variation of incremental costs of 2 L transplant-ineligible DLBCL interventions as a function of time leading to amortization of high-priced interventions.